Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy

Cancer Gene Therapy

Volumn 9, Issue 9, 2002, Pages 725-736

  Kim, Jaesung ^a   Cho, Jae Yong ^b   Kim, Joo Hang ^a   Jung, Kyeong Cheon ^c   Yun, Chae Ok ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Hallym University College of Medicine   (South Korea)

Author keywords

Cancer gene therapy; E1B 19 kDa gene; E1B 55 kDa gene; E1B mutant replicating adenovirus

Indexed keywords

DNA FRAGMENT; E1B PROTEIN; GENE PRODUCT; UNCLASSIFIED DRUG; PACLITAXEL; PRIMER DNA; VIRUS DNA;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CELL ORGANELLE; CELL STRUCTURE; CONTROLLED STUDY; CYTOLYSIS; GENE DELETION; GENE FUNCTION; GENE REPLICATION; GENE THERAPY; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL; TREATMENT PLANNING; VIRUS REPLICATION; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; CHEMISTRY; CLONOGENIC ASSAY; EXPERIMENTAL NEOPLASM; FEMALE; GENE VECTOR; GENETICS; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; VIRUS CULTURE; WESTERN BLOTTING;

ADENOVIRIDAE; ADENOVIRUS E1B PROTEINS; ANIMAL; BLOTTING, WESTERN; CELL DIVISION; COLONY-FORMING UNITS ASSAY; DNA PRIMERS; DNA, VIRAL; FEMALE; GENE DELETION; GENE THERAPY; GENETIC VECTORS; HUMAN; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PACLITAXEL; PLAQUE ASSAY; POLYMERASE CHAIN REACTION; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; VIRUS REPLICATION; ANIMALS; HUMANS;

ADENOVIRIDAE;

EID: 0036708228     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700494     Document Type: Article

References (48)

1. Replication selective oncolytic adenoviruses: Virotherapy aimed at genetic targets in cancer
2. Clinical research results with d11520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: What have we learned?
3. Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
4. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: A phase I trial
5. A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer
6. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55 kD gene-deleted adenovirus, in patients with advanced head and neck cancer: A phase II trial
7. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
8. A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience)
9. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins
10. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells
11. Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly (ADP-ribose) polymerase
12. Interaction of E1B 19 K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis
13. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins
14. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B
15. Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein
16. Bcl-2, Bcl-XL and adenovirus protein E1B19 kD are functionally equivalent in their ability to inhibit cell death
17. Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer
18. Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines
19. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport
20. Interaction of adenoviral E4 and E1b products in late gene expression
21. Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence
22. Oncolytic potential of E1B 55 kDa-deleted YKL-1 recombinant adenovirus: Correlation with p53 functional status
23. Deletion of the adenoviral E1b-19 kD gene enhances tumor cell killing of a replicating adenoviral vector
24. Apoptosis in chicken embryo fibroblasts caused by Newcastle disease virus
25. Human herpesvirus 7 induces CD4(+) T-cell death by two distinct mechanisms: Necrotic lysis in productively infected cells and apoptosis in uninfected or nonproductively infected cells
26. Apoptosis precedes necrosis of fish cell line with infectious pancreatic necrosis virus infection
27. A biochemical hallmark of apoptosis: Internucleosomal degradation of the genome
28. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor
29. The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function
30. Enhanced expression of p53 in human cells infected with mutant adenoviruses
31. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells
32. The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells
33. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff
34. The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs
35. The adenovirus E1B 55 kd protein influences mRNA transport via an intranuclear effect on RNA metabolism
36. Deletion of the gene encoding the adenovirus 5 early region 1b 21, 000-molecular-weight polypeptide leads to degradation of viral and host cell DNA
37. 19-kDa tumor antigen coded by early region E1b of adenovirus 2 is required for efficient synthesis and for protection of viral DNA
38. + locus, which codes for a 19-kilodalton tumor antigen
39. Cyt gene of adenoviruses 2 and 5 is an oncogene for transforming function in early region E1B and encodes the E1B 19, 000-molecular-weight polypeptide
40. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins
41. Regulation of adenovirus gene expression in human W138 cells by an E1B-encoded tumor antigen
42. Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis
43. The E1B 19, 000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells
44. Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUCI antigen
45. Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein
46. Mutational analysis of the transforming and apoptosis suppression activities of the adenovirus E1B 175R protein
47. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
48. The adenovirus death protein (E3-11.6 K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells